Order Article Reprints

Eso Y, Nakano S, Mishima M, Arasawa S, Iguchi E, Nakamura F, Takeda H, Takai A, Takahashi K, Taura K, et al. Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular Carcinoma. Cancers. 2020; 12(1):49. https://doi.org/10.3390/cancers12010049

Eso, Yuji, Shigeharu Nakano, Masako Mishima, Soichi Arasawa, Eriko Iguchi, Fumiyasu Nakamura, Haruhiko Takeda, Atsushi Takai, Ken Takahashi, Kojiro Taura, and et al. 2020. "Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular Carcinoma" Cancers 12, no. 1: 49. https://doi.org/10.3390/cancers12010049

Eso, Y., Nakano, S., Mishima, M., Arasawa, S., Iguchi, E., Nakamura, F., Takeda, H., Takai, A., Takahashi, K., Taura, K., & Seno, H. (2020). Dose Intensity/Body Surface Area Ratio is a Novel Marker Useful for Predicting Response to Lenvatinib against Hepatocellular Carcinoma. Cancers, 12(1), 49. https://doi.org/10.3390/cancers12010049